| Proposed Ticker: USMI | 16825 Via Del Campo Court | |
| Exchange: NASDAQ-National Market | San Diego, California 92127 | |
| Industry: Wholesale | (619) 674-7200 |
| All share information is proposed | ||||
| Type of Shares: | Common Shares | Filing Date: | 9/9/96 | |
| U.S. Shares Filed: | 0 | Filing Price: | - | |
| Non-U.S. Shares Filed: | 0 | Offering Amount: | $25,300,000 | |
| Primary Shares: | 0 | Expenses: | - | |
| Secondary Shares: | 0 | Shs Out After: | ||
| Manager | Tier | Phone |
| Rodman & Renshaw, Inc. | Lead Manager | (312) 977-7824 |
| Audited Income | Latest Unaudited Income | Prior Unaudited Income | Balance Sheet | ||
| 1/31/96 | 4/30/96 | 4/30/96 | 4/3/96 | ||
| Revenue: | $0.37 | $0.22 | $0.02 | Assets: | $12.35 |
| Net Income: | -$8.81 | -$1.72 | -$2.15 | Liabilities: | $4.28 |
| EPS: | Equity: | $8.07 | |||
Note: Dollar amounts are in U.S. millions; Audited figures expressed as full year, unaudited figures are partial year | |||||
| Business Description |
| The company designs, develops, manufactures and markets proprietary, safety-enhanced, disposable medical products intended to protect healthcare workers from the spread of infectious diseases such as AIDS and hepatitis. The company's first product line, the SafeSnap syringe is similar in appearance, size and manner of use to a standard syringe; however, it incorporates patented retraction and encapsulation technology that permits the isolation of the needle within the barrel of the syringe immediately after use, thereby facilitating safe disposal. The SafeSnap product line consists of four syringes which vary by size, needle length and gauge. The SafeSnap syringe is also latex-free and will not cause adverse reactions in the estimated 8-10% of patients and healthcare workers with allergies to latex. The company believes that the SafeSnap syringe is the only safety syringe currently on the market that is latex free. |
| Use of Proceeds |
| The proceeds from the proposed offering will be used for the purchase of capital equipment for manufacturing and assembly; marketing, sales and advertising; development of additional product lines; and general corporate purposes. |
©1996 IPO Data Systems, Inc. - All rights reserved.